EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic target

Feyza Gul Ozbay Kurt, Samantha Lasser, Ihor Arkhypov, Jochen Utikal, Viktor Umansky

Journal of Clinical Investigation · 03.07.2023 · 133 (13)

DOI: 10.1172/jci170762 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Investigation, online erschienen am 03.07.2023. Verfasst von Feyza Gul Ozbay Kurt und 4 weiteren Autor:innen. Beteiligte Einrichtung: Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany. Hauptthemen laut MEDLINE: Myeloid-Derived Suppressor Cells, Melanoma. Die Arbeit wurde bisher 105-mal zitiert (Crossref) und nennt 165 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myeloid-Derived Suppressor CellsMelanomaHumansImmunotherapyKiller Cells, NaturalTumor Microenvironment

Autor:innen und Institutionen

  • Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karls University of Heidelberg, Mannheim, Germany.
  • DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, Mannheim, Germany.
  • Mannheim Institute for Innate Immunoscience (MI3), Medical Faculty Mannheim, Ruprecht-Karls University of Heidelberg, Mannheim, Germany.

Zitieren

APA

Ozbay Kurt, F. G., Lasser, S., Arkhypov, I., Utikal, J., & Umansky, V. (2023). Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic target. Journal of Clinical Investigation, 133(13). https://doi.org/10.1172/jci170762

Vancouver

Ozbay Kurt FG, Lasser S, Arkhypov I, Utikal J, Umansky V. Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic target. Journal of Clinical Investigation. 2023;133(13). doi:10.1172/jci170762

BibTeX
@article{OzbayKurt2023,
  author = {Ozbay Kurt, Feyza Gul and Lasser, Samantha and Arkhypov, Ihor and Utikal, Jochen and Umansky, Viktor},
  title = {Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic target},
  journal = {Journal of Clinical Investigation},
  year = {2023},
  volume = {133},
  number = {13},
  doi = {10.1172/jci170762}
}
Kostenlos starten →